Company / Revenue per Share
Arcus Biosciences, Inc. Revenue per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$2.68
FY2025
5-year range
$1.10 / $5.88
FY2021-FY2025
Trend
-21.6%
vs FY2024
Sector context
#78 of 154
Health Care
What the data says
At $2.68, Arcus Biosciences, Inc.'s revenue per share ranks #78 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 9 years, ranging from $0.04 in FY2019 to $5.88 in FY2021.
Based on SEC 10-K filings.
2.68 in FY2025 with a 5-year CAGR of +71.3%.
Improved from $1.60 to $2.68 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +34.5%
- 5-Year CAGR
- +71.3%
- 10-Year CAGR
- -
Sector benchmark
#78 of 154 in Health CareTop 51% of 154This company $2.68 Sector average $15.09
▼
-82.2% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 21.6% year-over-year.
- Ranks #78 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.68 | -21.6% |
| FY2024 | $3.42 | +112.9% |
| FY2023 | $1.60 | +45.7% |
| FY2022 | $1.10 | -81.3% |
| FY2021 | $5.88 | +3133.9% |
| FY2020 | $0.18 | +362.9% |
| FY2019 | $0.04 | -88.6% |
| FY2018 | $0.35 | -55.3% |
| FY2017 | $0.77 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026